Hang Lung Group Ltd
HKEX:10
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.15
11.36
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Hang Lung Group Ltd
Cost of Revenue
Hang Lung Group Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
H
|
Hang Lung Group Ltd
HKEX:10
|
Cost of Revenue
-HK$4.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-4%
|
|
W
|
Wharf Real Estate Investment Company Ltd
HKEX:1997
|
Cost of Revenue
-HK$2.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
S
|
Swire Properties Ltd
HKEX:1972
|
Cost of Revenue
-HK$4.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
Hang Lung Properties Ltd
HKEX:101
|
Cost of Revenue
-HK$4.2B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-4%
|
||
Hysan Development Co Ltd
HKEX:14
|
Cost of Revenue
-HK$643m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
||
A
|
Art Group Holdings Ltd
HKEX:565
|
Cost of Revenue
-HK$39.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
9%
|
CAGR 10-Years
21%
|
Hang Lung Group Ltd
Glance View
Hang Lung Group Ltd. is an investment holding company, which engages in the property development, property investment, and other investments. The firm operates its business through two segments. The Property Leasing segments engages in the property leasing operation. The Company’s investment properties portfolio consists of retail, office, residential, serviced apartments and car parks, are primarily located in mainland China and Hong Kong. Property Sales segment engages in the development and sale of the trading properties in mainland China and Hong Kong.
See Also
What is Hang Lung Group Ltd's Cost of Revenue?
Cost of Revenue
-4.4B
HKD
Based on the financial report for Jun 30, 2024, Hang Lung Group Ltd's Cost of Revenue amounts to -4.4B HKD.
What is Hang Lung Group Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-4%
Over the last year, the Cost of Revenue growth was -42%. The average annual Cost of Revenue growth rates for Hang Lung Group Ltd have been -15% over the past three years , -14% over the past five years , and -4% over the past ten years .